Bio Rad Cytokine/chemokin kits & reagents
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Points of contact
-
- CBER Acquisition Liaison cberacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring Bio Rad Cytokine/chemokine kits and reagents under a new requirement with solicitation release estimated for April 1, 2027, and award targeted for June 1, 2027. This is a non-set-aside requirement classified under research and development in the physical, engineering, and life sciences.
The estimated award value ranges from $25,000 to $250,000. Inquiries should be directed to the FDA's Center for Biologics Evaluation and Research Acquisitions mailbox at cberacquisitions@fda.hhs.gov.
Forecast text
Bio Rad Cytokine/chemokin kits & reagents
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast